These findings are consistent with our previous results in NAFLD mice showing that AB23A maintains intestinal barrier integrity by inhibiting HFD-induced downregulation of TJ expressions, including ZO-1 and occludin (Xia et al., 2021). The gene discussed is OCLN; the disease is metabolic dysfunction-associated steatotic liver disease.